Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$473.42 - $539.26 $48 Million - $54.6 Million
-101,300 Reduced 75.37%
33,100 $17.8 Million
Q4 2023

Feb 13, 2024

BUY
$437.42 - $470.64 $30.6 Million - $32.9 Million
69,900 Added 108.37%
134,400 $62.2 Million
Q3 2023

May 14, 2024

SELL
$402.4 - $446.42 $28.1 Million - $31.2 Million
-69,900 Reduced 52.01%
64,500 $28 Million
Q3 2023

Nov 14, 2023

BUY
$402.4 - $446.42 $21.6 Million - $24 Million
53,800 Added 502.8%
64,500 $28 Million
Q2 2023

May 14, 2024

SELL
$354.01 - $427.31 $43.8 Million - $52.9 Million
-123,700 Reduced 92.04%
10,700 $4.57 Million
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $3.79 Million - $4.57 Million
10,700 New
10,700 $4.57 Million
Q4 2021

Feb 14, 2022

SELL
$198.21 - $248.9 $2.97 Million - $3.73 Million
-15,000 Reduced 42.86%
20,000 $4.97 Million
Q3 2021

Nov 10, 2021

BUY
$188.42 - $208.66 $6.59 Million - $7.3 Million
35,000 New
35,000 $6.98 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.